| GBM | Glioblastoma |
| IDH1/2 | Isocitrate dehydrogenase 1 or 2 |
| MGMT | O6-methylguanine-DNA methyltransferase |
| TMZ | Temozolomide |
| TPPs | Pyrazolone-based hydrazone compounds |
| HQPh,Bn | 1-(5-hydroxy-3-methyl-1-phenyl-1H-pyrazol-4-yl)-2-phenylethan-1-one |
| h | hours |
| IC50 | Half-maximal inhibitory concentration |
| MTT | 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide |
| n.c. | Not cytotoxic |
| n.f. | Not fittable |
| SEM | Standard Error of the Mean |
| IC25 | Concentration that leaves 75% of cells viable (i.e., only 25% growth inhibition). |
| ɣ-H2AX | Phosphorylated histone H2AX |
| DSBs | Double-strand breaks |
| GAPDH | Glyceraldehyde 3-phosphate dehydrogenase |
| PI | Propidium iodide |
| MFI | Mean Fluorescence Intensity |
| ROS | Reactive oxygen species |
| DCFDA | 2′,7′-dichlorodihydrofluorescein diacetate |
| DCF | 2′,7′-dichlorofluorescein |
| H2O2 | Hydrogen peroxide |
| ΔΨm | Mitochondrial membrane potential |
| CCCP | Carbonyl cyanide m-chlorophenyl hydrazone |
| EMEM | Eagle’s Minimum Essential Medium |
| FBS | Fetal bovine serum |
| DMEM | Dulbecco’s Modified Eagle’s Medium |
| DMSO | Dimethyl sulfoxide |
| JC1 | 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraehylbenzimidazolylcarbocyanineiodide |